Some experts fear that recent reforms instated by the Centers for Medicare and Medicaid Services may lead to the closure of some dialysis facilities that treat patients with kidney failure. When investigators analyzed data ...
Oct 4, 2021
0
4
Researchers at the University of Southern California have developed an economic model to quantify the benefits of treatment for wet age-related macular degeneration (wAMD), the leading cause of blindness in western countries. ...
Nov 15, 2019
0
145
Novo Nordisk A/S replenished supplies of Ozempic, a treatment for diabetes, after social media-driven enthusiasm over the drug's use for weight loss led to six months of shortages.
Mar 20, 2023
0
2
Up to 90% of patients experiencing a stroke have sleep apnoea, according to earlier studies conducted at Kuopio University Hospital. If left untreated, sleep apnoea can reduce the quality of life and rehabilitation of patients ...
Jan 26, 2021
0
6
An innovative technique called burst wave lithotripsy (BWL) may provide an effective, more accessible alternative for noninvasive treatment of kidney stones, according to initial human studies reported in the Journal of ...
Mar 22, 2022
0
20
The use of time-lapse monitoring in IVF does not result in more pregnancies or shorten the time it takes to get pregnant. This new method, which promises to "identify the most viable embryos," is more expensive than the classic ...
Mar 30, 2023
0
42
High housing costs, frequent moves and homelessness are higher among cancer survivors and can negatively affect their long-term care, according to a new study by researchers at the Medical College of Georgia at Augusta University.
Feb 4, 2022
0
34
Everyday, 1,000 people in Canada turn 65, entering a stage of life that has increasing risk of stroke and Alzheimer's disease.
Oct 4, 2011
0
0
In June 2021, the Food & Drug Administration (FDA) granted accelerated approval for aducanumab to treat patients with mild cognitive impairment or mild dementia due to Alzheimer's disease. The two phase-3 clinical trials ...
Sep 9, 2021
0
3
A new blood test called p-tau217 shows promise as an Alzheimer's disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude brain amyloidosis, the most important and earliest ...
Aug 31, 2023
0
31
